Get the full picture
Sign in to uncover key details.
GeoVax
Business Services · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1955 Lake Park Dr SE Ste 300, Smyrna, Ge...Phone Number
(678) 384-7220Website
www.geovax.comRevenue
-Stock Symbol
GOVXIndustry
About GeoVax
GeoVax Labs, Inc. is a clinical-stage biotechnology company headquartered in the Smyrna, Georgia metropolitan area. The company develops vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers using its proprietary Modified Vaccinia Ankara vector platform. Its priority program, GEO-MVA, targets mpox and smallpox, while its pipeline also includes a next-generation COVID-19 vaccine, a gene-directed therapy for head and neck cancer, and preclinical candidates for Ebola, Marburg, Lassa fever, Zika, and malaria.Explore more
GeoVax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to GeoVax
Compare insights from companies similar to GeoVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
GeoVax Tech Stack
A closer look at the technologies used by GeoVax
See more technologies
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding GeoVax
Sign Up For FreeTo access detailed company insights
GeoVax Labs, Inc. is a clinical-stage biotechnology company headquartered in the Smyrna, Georgia metropolitan area. The company develops vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers using its proprietary Modified Vaccinia Ankara vector platform. Its priority program, GEO-MVA, targets mpox and... Read More
